Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes.

Shi MM, Myrand SP, Bleavins MR, de la Iglesia FA.

Mol Pathol. 1999 Oct;52(5):295-9.

PMID:
10748880
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population.

Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC.

Lung Cancer. 2001 Nov;34(2):177-83.

PMID:
11679176
[PubMed - indexed for MEDLINE]
3.

High-throughput genotyping method for glutathione S-transferase T1 and M1 gene deletions using TaqMan probes.

Shi MM, Myrand SP, Bleavins MR, de la Iglesia FA.

Res Commun Mol Pathol Pharmacol. 1999 Jan;103(1):3-15.

PMID:
10440566
[PubMed - indexed for MEDLINE]
4.

NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations.

Gaedigk A, Tyndale RF, Jurima-Romet M, Sellers EM, Grant DM, Leeder JS.

Pharmacogenetics. 1998 Aug;8(4):305-13.

PMID:
9731717
[PubMed - indexed for MEDLINE]
5.

Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1.

Siegel D, McGuinness SM, Winski SL, Ross D.

Pharmacogenetics. 1999 Feb;9(1):113-21. Erratum in: Pharmacogenetics 1999 Jun;9(3):419.

PMID:
10208650
[PubMed - indexed for MEDLINE]
6.

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, Ross D.

Br J Cancer. 1997;75(1):69-75.

PMID:
9000600
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer.

Harth V, Donat S, Ko Y, Abel J, Vetter H, Brüning T.

Arch Toxicol. 2000 Jan;73(10-11):528-31.

PMID:
10663383
[PubMed - indexed for MEDLINE]
8.

Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C.

Fleming RA, Drees J, Loggie BW, Russell GB, Geisinger KR, Morris RT, Sachs D, McQuellon RP.

Pharmacogenetics. 2002 Jan;12(1):31-7.

PMID:
11773862
[PubMed - indexed for MEDLINE]
9.

[Establishment and preliminary application of polymerase chain reaction with confronting two-pair primers for the single nucleotide polymorphisms of metabolic enzymes].

Fu J, Yang YR, Ni XJ, Pan XD, Zheng JJ, Zheng SL, Lin RY, Cai M, Chen BC.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Jan;30(1):63-7. Chinese.

PMID:
19565852
[PubMed - indexed for MEDLINE]
10.

609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia.

Steiner M, Hillenbrand M, Borkowsi M, Seiter H, Schuff-Werner P.

Cancer Lett. 1999 Jan 8;135(1):67-71.

PMID:
10077223
[PubMed - indexed for MEDLINE]
11.

NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.

Jamieson D, Wilson K, Pridgeon S, Margetts JP, Edmondson RJ, Leung HY, Knox R, Boddy AV.

Clin Cancer Res. 2007 Mar 1;13(5):1584-90.

PMID:
17332305
[PubMed - indexed for MEDLINE]
Free Article
12.

Detection of single nucleotide polymorphisms in the mannose-binding lectin gene using minor groove binder-DNA probes.

Van Hoeyveld E, Houtmeyers F, Massonet C, Moens L, Van Ranst M, Blanckaert N, Bossuyt X.

J Immunol Methods. 2004 Apr;287(1-2):227-30.

PMID:
15099770
[PubMed - indexed for MEDLINE]
13.

[A new, rapid and robust genotyping method for CYP2C9 and MDR1].

Verstuyft C, Morin S, Yang J, Loriot MA, Barbu V, Kerb R, Brinkmann U, Beaune P, Jaillon P, Becquemont L.

Ann Biol Clin (Paris). 2003 May-Jun;61(3):305-9. French.

PMID:
12805007
[PubMed - indexed for MEDLINE]
14.

No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.

Akkiz H, Bayram S, Bekar A, Akgöllü E, Ülger Y, Kaya BY, Sandikçi M, Özdil B.

Asian Pac J Cancer Prev. 2010;11(4):1051-8.

PMID:
21133623
[PubMed - indexed for MEDLINE]
Free Article
15.

Large-scale genotyping of single nucleotide polymorphisms by Pyrosequencingtrade mark and validation against the 5'nuclease (Taqman((R))) assay.

Nordfors L, Jansson M, Sandberg G, Lavebratt C, Sengul S, Schalling M, Arner P.

Hum Mutat. 2002 Apr;19(4):395-401.

PMID:
11933193
[PubMed - indexed for MEDLINE]
16.

Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies.

Shi MM.

Clin Chem. 2001 Feb;47(2):164-72. Review.

PMID:
11159763
[PubMed - indexed for MEDLINE]
Free Article
17.

TaqMan genotyping of insertion/deletion polymorphisms.

Robledo R, Beggs WR, Bender PK.

Methods Mol Biol. 2005;311:165-76.

PMID:
16100407
[PubMed - indexed for MEDLINE]
18.

Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking.

Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH.

Pharmacogenetics. 1995 Aug;5(4):199-206.

PMID:
8528266
[PubMed - indexed for MEDLINE]
19.

[Establishing a single-tube fluorescent bidirectional PCR method to detect the 609C/T polymorphism of NQO1 gene].

Ye R, Lai Y, Pan JC.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Apr;25(2):230-2. Chinese.

PMID:
18393254
[PubMed - indexed for MEDLINE]
20.

Prevalence of H63D, S65C and C282Y hereditary hemochromatosis gene mutations in Slovenian population by an improved high-throughput genotyping assay.

Cukjati M, Vaupotic T, Rupreht R, Curin-Serbec V.

BMC Med Genet. 2007 Nov 23;8:69.

PMID:
18036208
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk